Lars Gille, PhD

University of Veterinary Medicine, Vienna (Austria)

Sergi Segarra, PhD

Bioiberica (Spain)

Ingo Schäfer, PhD

Laboklin GmbH & Co. KG, Department of Clinical Pathology, Bad Kissingen, Bavaria (Germany)

Feline leishmaniosis: a practical approach with clinical signs, diagnostics, therapy and management

Albert Descoteaux, PhD

INRS (Canada)

Inter-organelle communication in Leishmania-infected macrophages

Dan Zilberstein, PhD

Technion – Israel Institute of Technology (Israel)

The arginine sensing pathway in Leishmania

Márcia Dalastra Laurenti, PhD

Medical School, University of São Paulo, São Paulo (Brazil)

Non-Ulcerated Cutaneous Leishmaniasis, a Benign Clinical Form of Leishmania (L.) infantum chagasi Infection

Marie Lipoldová, PhD

Charles University in Prague (Czech Republic)

Role of interferon-induced GTPases in leishmaniasis

Carolina Rodriguez-Cariño, PhD

Veterinary Pathologist, Clinical Pathology Department, IDEXX laboratories Iberia, Barcelona (Spain)

Pericardial effusion as a clinical manifestation of canine leishmaniosis

Paul Denny, PhD

Durham University, Durham (UK)

Sanjai Nagendra, MD

Medical Director Center for Esoteric Testing and Atlantic Regional Labs, Burlington (USA)

Angela Kaysel Cruz, PhD

São Paulo University, São Paulo (Brazil)

Ger van Zandbergen, PhD

Federal Institute for Vaccines and Biomedicines, Berlin (Germany)

Parasite and host cell signals driving Leishmania propagation in human macrophages

William Kerr, PhD

Ospedale Policlinico San Martino/SUNY Upstate Medical University, New York (USA)

Inhibition of the SHIP1/2 paralogs to combat infection and disease